Detalhe da pesquisa
1.
Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex.
AIDS Care
; 36(1): 80-86, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37066990
2.
Elevated Risk of Bacterial Vaginosis Among Users of the Copper Intrauterine Device: A Prospective Longitudinal Cohort Study.
Clin Infect Dis
; 73(3): 513-520, 2021 08 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32505132
3.
The Influence of Perceived Dapivirine Vaginal Ring Effectiveness on Social Disclosure and Ring Adherence.
AIDS Behav
; 25(12): 4169-4179, 2021 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-33939034
4.
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women.
N Engl J Med
; 375(22): 2121-2132, 2016 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26900902
5.
High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Nat Commun
; 14(1): 8299, 2023 Dec 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38097552
6.
Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial.
J Acquir Immune Defic Syndr
; 90(4): 418-424, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35344520
7.
Prevalent human papillomavirus infection increases the risk of HIV acquisition in African women: advancing the argument for human papillomavirus immunization.
AIDS
; 36(2): 257-265, 2022 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34172672
8.
Infusion Reactions After Receiving the Broadly Neutralizing Antibody VRC01 or Placebo to Reduce HIV-1 Acquisition: Results From the Phase 2b Antibody-Mediated Prevention Randomized Trials.
J Acquir Immune Defic Syndr
; 89(4): 405-413, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34923559
9.
Pharmacokinetics and predicted neutralisation coverage of VRC01 in HIV-uninfected participants of the Antibody Mediated Prevention (AMP) trials.
EBioMedicine
; 64: 103203, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33493795
10.
Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study.
Lancet HIV
; 8(2): e87-e95, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33539762
11.
Use of the dapivirine vaginal ring and effect on cervical cytology abnormalities.
AIDS
; 34(4): 559-567, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31764068
12.
Social harms in female-initiated HIV prevention method research: state of the evidence.
AIDS
; 33(14): 2237-2244, 2019 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31408030
13.
Author Correction: High monoclonal neutralization titers reduced breakthrough HIV-1 viral loads in the Antibody Mediated Prevention trials.
Nat Commun
; 15(1): 2575, 2024 Mar 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38519455
14.
Impact of Partner-Related Social Harms on Women's Adherence to the Dapivirine Vaginal Ring During a Phase III Trial.
J Acquir Immune Defic Syndr
; 79(5): 580-589, 2018 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30239426
15.
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
J Acquir Immune Defic Syndr
; 76(2): e47-e51, 2017 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28542081
16.
Performance of a Validated Risk Score to Predict HIV-1 Acquisition Among African Women Participating in a Trial of the Dapivirine Vaginal Ring.
J Acquir Immune Defic Syndr
; 77(1): e8-e10, 2018 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28961677